858340-91-7 Usage
Uses
Used in Pharmaceutical Industry:
1H-Pyrrolo[2,3-b]pyridine-3-carboxylic acid, 5-nitro-1-(phenylsulfonyl)-, methyl ester is used as a precursor in the synthesis of new drugs and biologically active molecules for various therapeutic applications. Its unique structure and properties make it a promising candidate for the development of innovative pharmaceutical agents.
Used in Research Applications:
In the research industry, 1H-Pyrrolo[2,3-b]pyridine-3-carboxylic acid, 5-nitro-1-(phenylsulfonyl)-, methyl ester serves as a valuable compound for studying its chemical properties, reactivity, and potential interactions with biological systems. This research can contribute to a deeper understanding of its behavior and pave the way for new applications in medicine and other fields.
Check Digit Verification of cas no
The CAS Registry Mumber 858340-91-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,8,3,4 and 0 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 858340-91:
(8*8)+(7*5)+(6*8)+(5*3)+(4*4)+(3*0)+(2*9)+(1*1)=197
197 % 10 = 7
So 858340-91-7 is a valid CAS Registry Number.
InChI:InChI=1/C15H11N3O6S/c1-24-15(19)13-9-17(25(22,23)11-5-3-2-4-6-11)14-12(13)7-10(8-16-14)18(20)21/h2-9H,1H3
858340-91-7Relevant academic research and scientific papers
PYRROLO[2,3-b]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
-
Page/Page column 37, (2010/02/12)
Compounds which are pyrrolo[2,3-b]pyridine derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by
PYRROLO[2,3-b] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION COMPRISING THEM
-
Page/Page column 41, (2008/06/13)
Compounds which are pyrrolo[2,3-b]pyridine derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by
